Medical Devices Acquisitions in 2025

Healthcare Holding Schweiz AG, backed and managed by Winterberg Advisory and KKA Partners, has acquired a majority stake in Sevika Medical AG, a Baar-based distributor of orthopedic medical technologies. The deal establishes a new orthopedics-focused platform within Healthcare Holding to accelerate product introductions and growth in the Swiss market.

Solventum (NYSE: SOLV) has completed the acquisition of Acera Surgical, a privately held bioscience company that develops synthetic tissue matrices for regenerative wound care, for $725 million upfront plus up to $125 million in contingent payments. The deal expands Solventum's MedSurg and advanced wound care portfolio with Acera's synthetic electrospun matrix technology; Acera is expected to generate about $90 million in sales in 2025.

Healthcare Holding Schweiz AG has acquired a stake in KSM Kunden Service Management GmbH, a Swiss specialist in single‑use medical supplies headquartered in Mont‑Vully. KSM's management will remain in place and will take a stake in Healthcare Holding; the acquisition is intended to expand Healthcare Holding's portfolio of disposable medical products and enable cross‑platform deployment of KSM's products and capabilities.

MidEuropa has acquired a majority stake in the MBL Group, a leading European contract development and manufacturing organisation (CDMO) for assisted mobility, rehabilitation and aged-care equipment. INVL Baltic Sea Growth Fund has fully exited its shareholding while the Lauritsen family has reinvested and CEO Martin Lauritsen will continue to lead the business as MidEuropa supports international growth and capability expansion. MBL employs approximately 1,700 people across Europe and Asia and holds over 100 registered patents.

OSR Holdings, Inc. announced that shareholders of Woori IO Co., Ltd. approved a share exchange that will make Woori IO a wholly-owned subsidiary of OSR Holdings' Korean intermediate holding company (OSR Holdings Co., Ltd.). The acquisition brings Woori IO's noninvasive glucose-monitoring and wearable biosensing technology into the OSR Group to support regulatory, clinical and commercial expansion in Korea and the United States.

Ion Beam Applications S.A. (IBA) has acquired ORA Group (ORA - Optimized Radiochemical Applications SRL and OOC) to strengthen its leadership in nuclear medicine and radiochemistry. The cash-free, debt-free transaction (total consideration €15–20 million) is financed from IBA’s own funds and existing credit facilities and is immediately accretive to IBA Technologies’ revenue and EBITDA; ORA founder Vincent Tadino will continue with the combined business as CTO.

KVP International has acquired SafePath Laboratories and IVD Research (together SafePath-IVD), a Carlsbad, California–based diagnostics manufacturer and CDMO with FDA, ISO 13485 and USDA licenses. KVP will use SafePath-IVD as its dedicated research, development and manufacturing partner to expand veterinary point-of-care diagnostics while supporting SafePath-IVD's continued growth in human diagnostics and CDMO services.

Surmodics has completed a merger with Biocoat and formed a new division, Surmodics Services & Technologies (SST), to carry forward the portion of Biocoat's business remaining after divesting certain assets. SST, based in Horsham, Pennsylvania, will provide hydrophilic coating technologies, custom polymer formulations and full-service coating operations to medical device manufacturers worldwide.

Aptyx has acquired Argos Corporation, a Massachusetts-based precision extrusion specialist, and will establish a Boston-area Precision Extrusion Center of Excellence to expand medical tubing and catheter-grade extrusion capacity. The deal enhances Aptyx’s capabilities for interventional and catheter-based device markets, adding in-house tooling and micro-extrusion expertise to its integrated medical manufacturing platform.

CQ Medical has acquired the Radiation Therapy business unit from Bionix, expanding CQ Medical’s patient positioning and radiotherapy marking product portfolio. The deal transfers Bionix’s radiation therapy product lines and commercial team to CQ Medical while Bionix retains its Ambulatory Care business based in Maumee, Ohio.

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) has completed the acquisition of Liora Technologies Europe Ltd., a UK-based developer of the LiGHT proton therapy system. The deal brings Liora's proprietary LiGHT System and Daresbury-based operations into LIXTE as a wholly owned subsidiary to expand the company's capabilities into radiotherapy and pursue joint treatment-center revenue models.

Abyrx, Inc. and Kairuku, Inc. completed a combined $450 million management-led buyout and capital raise to form MedEdge Holdings LLC. The new holding company will integrate Abyrx's biosurgical product portfolio with Kairuku's SaaS commercial operations platform and deploy capital to acquire 10–15 commercial-stage surgical product companies to accelerate growth and streamline product delivery to operating rooms.

Poly Medicure Ltd has acquired Medistream SA (doing business as Citieffe), an Italian maker of orthopedic implants, from ARCHIMED MedTech. The deal expands Poly Medicure’s product portfolio and international footprint by combining Citieffe’s trauma and limb-reconstruction technology and US/European presence with Poly Medicure’s manufacturing scale and global commercial network.

Vance Street Capital has acquired Injectech from The West Group and added it to its newly formed VSC Medical Molding platform, expanding the platform's precision injection-molding and single-use fluid management capabilities for medical device, life science and bioprocessing customers. Injectech, headquartered in Fort Collins, Colorado, will operate alongside Resenex under the VSC Medical Molding platform to broaden component offerings and custom manufacturing capabilities.

Digital-first home healthcare provider Cera has acquired GenieConnect, a UK care-robotics platform, to scale the robot-assisted remote care technology across its operations and the wider UK care sector. Financial terms were not disclosed; Cera says the robots improve medication, food and drink adherence, boost providers' care capacity and can deliver material per-patient cost savings.

Alcedo SGR (via its Alcedo V fund) has completed the acquisition of a majority stake in Operamed S.r.l., an Italian designer and supplier of prefabricated medical systems for critical hospital areas. The stake was previously held by Itago SGR (Itago IV fund) and minority shareholders; the deal represents a PE sponsor exit and a platform / capability investment by Alcedo into hospital infrastructure solutions.

Kingsway Pharmaceuticals acquired a strategic minority equity stake in CIGA Healthcare to accelerate expansion of at-home and retail diagnostic testing in the United States. The partnership creates a joint-venture alignment to strengthen Kingsway's supply chain, broaden private-label and branded diagnostic offerings for U.S. retailers, and open new U.S. channels for CIGA's rapid-test portfolio.

Prescott's Med has acquired Tenacore, a Costa Mesa, California-based provider of depot-based medical device repair, parts, and technical support. The deal expands Prescott's Med's nationwide depot footprint and service capabilities for hospitals, ISOs, and in-house biomedical departments.

Evident has completed its acquisition of Pramana, Inc., a Cambridge-based developer of autonomous whole slide imaging systems for digital pathology. The deal brings Pramana's AI-powered imaging and workflow technology into Evident's microscopy and optical-imaging portfolio to accelerate digital pathology capabilities and broaden solutions for hospitals, research institutions, and laboratories.

JLL Partners has acquired Parks Medical Electronics and merged the business with Vascular Technology to create a vascular diagnostics and robotics-focused medical device platform. The combination brings Parks Medical's Doppler ultrasound product line together with Vascular Technology's intraoperative systems to expand the combined company's product portfolio and clinical reach across hospital, clinic, operating room, and veterinary markets.

Registrar Corp, a Paine Schwartz Partners portfolio company, has acquired CMC Medical Devices, a Spain-based regulatory, clinical, and compliance consulting firm for medical device and IVD manufacturers. The deal expands Registrar Corp's global representation, clinical capabilities, and regulatory services—strengthening its ability to help manufacturers access the U.S., EU and other key markets more quickly.

Premier Biotech, a portfolio company of Align Capital Partners, has acquired National Test Systems (NTS), a provider of rapid point-of-care drug screening supplies and services that serves more than 1,500 facilities across the United States. The acquisition expands Premier's point-of-care testing capabilities (including oral fluid testing) and deepens its presence in government and behavioral health end markets; NTS CEO Andrew Panico will remain involved to support the transition.

SK Capital Partners has completed the acquisition of LISI Group's Medical division and launched the business as Precera Medical, a precision medical device CDMO headquartered in Big Lake, Minnesota. LISI Group retained a minority stake; SK Capital plans to invest in capacity and capabilities and pursue organic growth and M&A to expand the new platform's service offerings to global medical device OEMs.

ARCHIMED Diagnostics (ARCHIMED’s diagnostics team) has acquired a 60% stake in Fremont-based ARK Diagnostics from Soulbrain Holdings in a transaction valuing ARK at $428 million. Soulbrain retains and reinvests in a 40% stake and the deal includes a joint-venture agreement to accelerate ARK’s product development and global expansion.

EQT Foundation has invested €100,000 via a SAFE in Hong Kong-based Syngular Technology to support scaling its AI- and AR-powered surgical guidance platform across Hong Kong and to build capacity for growing clinical demand. Syngular's system—used in 80+ real patient cases and piloted with the Hong Kong Hospital Authority—combines real-time AR overlays, AI anatomical segmentation and digital-twin generation to improve surgical precision and reduce operating time.

ARCHIMED MedTech, via its MED Platform II fund, has taken NASDAQ-listed ZimVie private in a $19.00-per-share cash transaction valuing the company at an enterprise value of approximately $730 million. Headquartered in Palm Beach Gardens, Florida, ZimVie is a global dental technology company (implants, regenerative biomaterials and digital dentistry) with ~1,700 employees; ARCHIMED plans to accelerate growth, invest in new product development and pursue selective complementary acquisitions.

Allegheny Performance Plastics has acquired Holbrook Tool and Molding, Inc., a precision injection molding and tooling company based in Meadville, Pennsylvania. The transaction expands Allegheny’s medical molding and tooling capabilities, adding tight-tolerance mold building and insert molding expertise for medical manufacturing.

Precision BioLogic Inc., a Halifax-based developer of hemostasis diagnostic products, has acquired George King Bio-Medical, Inc., a provider of fresh frozen human plasmas and hemostasis diagnostic reagents based in Overland Park, Kansas. The acquisition is intended to combine product portfolios and continue serving the bleeding disorders community while exploring new opportunities under the Precision BioLogic umbrella.

Los Angeles-based private equity firm Vance Street Capital has partnered with Molded Rubber and Plastic Corporation (MRPC), a family-owned, ISO 13485-certified medical device contract manufacturer headquartered in Butler, Wisconsin. Vance Street will support MRPC's capability and capacity expansion while existing CEO and shareholder Greg Riemer will remain in place; financial and legal advisors and lenders were disclosed but transaction terms were not.

Keensight Capital has acquired a majority stake in Bedfont Scientific Ltd., a UK-based designer and manufacturer of non-invasive breath analysis medical devices. The investment will support Bedfont's international expansion, product innovation and potential M&A-driven growth while existing shareholders reinvest alongside Keensight.

Promus Equity Partners, a Chicago-based private equity firm, completed its acquisition of Dr. Comfort from Enovis Corporation on October 7, 2025. Promus will operate Dr. Comfort as an independent business and partner with management — including newly appointed CEO Kunal Nandy — to invest in product innovation and strengthen the company's position in therapeutic diabetic footwear.

Zimmer Biomet Holdings, Inc. has completed the acquisition of Monogram Technologies Inc., an AI-driven orthopedic robotics company. The deal provides Zimmer Biomet with Monogram’s CT-based semi-autonomous and developing fully autonomous robotic technologies (Monogram’s mBôs TKA system) and was structured as a cash payment per share plus contingent value rights tied to future milestones.

GSI Group Holdings, a portfolio platform of L Squared Capital Partners, has acquired GenesisBPS, a designer and manufacturer of benchtop blood processing equipment and laboratory consumables. The add-on expands GSI Group’s capabilities in blood processing workflows and strengthens its global benchtop equipment and consumables platform.

Ahlstrom Oyj has acquired EBF (Eastern Business Forms), a Greenville, South Carolina–based manufacturer of 903 specimen collection cards and related newborn screening devices. The purchase brings EBF into Ahlstrom’s Filtration and Life Sciences division, strengthening Ahlstrom’s converting and card-manufacturing capabilities for diagnostic and life-science markets.

Artemis Capital Partners, a Boston-based private equity firm, has acquired Millrock Technology Inc., a Kingston, New York manufacturer of lyophilization (freeze-drying) instrumentation and process development tools for the pharmaceutical, biotech, and diagnostics markets. Under Artemis’ ownership Millrock will continue to operate independently from its Kingston facility while Artemis invests to scale the company’s technical capabilities and global reach.

Resonetics has acquired Eden Holdings (comprising Eden Manufacturing and Eden Tool), adding precision micro-molding, insert-molding, and advanced machining and tooling to its MedTech manufacturing capabilities. The deal expands Resonetics' polymer and tooling capabilities to better serve medical device OEM end markets including robotic surgery, minimally invasive surgery, electrophysiology, and rapid diagnostics.

Keensight Capital has acquired a majority stake in Isto Biologics, a US-based regenerative MedTech company focused on orthobiologic bone graft solutions. Thompson Street Capital Partners will retain a minority stake alongside Isto's management; Keensight plans to support Isto's international expansion and pursue additional acquisitions to accelerate growth.

Biogen has acquired Alcyone Therapeutics to obtain the ThecaFlex DRx intrathecal drug‑delivery system, integrating Alcyone employees into Biogen’s product delivery solutions team. Alcyone will receive $85 million upfront plus contingent milestone payments; Biogen will handle development, commercialization and manufacturing of ThecaFlex DRx while Alcyone’s remaining therapeutic assets are being divested into Neela Therapeutics.

Aspen Surgical, a portfolio company of Audax Private Equity, has acquired Cygnus Medical and Flagship Surgical to expand its perioperative product offering. The add-on deals broaden Aspen’s infection-prevention and OR safety capabilities and mark entry into the endoscopy market; financial terms were not disclosed.

SAM Medical has acquired TyTek Medical (part of the TyTek Group) to expand its proprietary emergency medical product offering. TyTek operations will be relocated to Tualatin, Oregon, and SAM will leverage its global reach to broaden customer support for TyTek’s chest decompression needles.

TEAM Technologies, a portfolio company of Arlington Capital Partners, has acquired TAG3 Engineering LLC, a MedTech design, development, and manufacturing firm based in Sunrise, Florida. The add-on expands TEAM Tech's front-end design, regulatory/V&V, and product innovation capabilities to accelerate speed-to-market across cardiovascular, neurovascular and other minimally invasive device markets.

Avanos Medical has acquired Nexus Medical, a privately held maker of the TKO anti-reflux needleless connector based in Lenexa, Kansas. The purchase adds Nexus' IV therapy connector technology to Avanos' Specialty Nutrition Systems business to strengthen medication and nutrition delivery in high-acuity settings such as NICUs and PICUs.

B. Braun SE has completed a full acquisition of True Digital Surgery (TDS), bringing the Goleta-based developer of robotic-assisted 3D surgical microscopy fully into its Aesculap surgical division. The deal integrates TDS's team and IP to accelerate development and global rollout of the AEOS digital exoscope platform for neurosurgery, spine and ENT procedures; financial terms were not disclosed.

MegaGen Implant, a South Korea–based dental implant manufacturer, has acquired BIOLASE, the Foothill Ranch, California–based leader in dental laser technology. The deal brings BIOLASE under MegaGen's ownership with MegaGen founder Dr. Kwang Bum Park named BIOLASE's new CEO and signals renewed investment, operational integration, and capability expansion of BIOLASE's product and service offerings.

Proclinic Group, a European dental platform backed by Miura Partners, has acquired Cenger Scandinavia, a leading dental distributor in Denmark with more than 1,300 clients and the number one distributor in the dental laboratory segment. The acquisition marks Proclinic Group's entry into the Nordic market and is intended to expand the Group's European footprint, enhance its service offering for dental professionals, and generate commercial synergies in the region.

Safe Life, a Sweden-based group focused on life-saving equipment, has acquired AED Brands, an Atlanta-area (Kennesaw, Georgia) distributor of automated external defibrillators, consumables and AED readiness services. The deal expands Safe Life's U.S. footprint and capabilities in AED sales and program services while preserving AED Brands' team and brand.

Schivo has acquired Mecaplast SA, a Swiss specialist in high-precision plastic, metal and ceramic injection molding and cleanroom assembly for MedTech and life sciences OEMs. The acquisition expands Schivo’s vertical integration and establishes Mecaplast’s Botterens facility as Schivo’s Global Center of Excellence for molding and precision manufacturing in Europe.

Quasar Medical has completed the acquisition of Nordson MEDICAL's design & development contract manufacturing businesses in Galway, Ireland and Tecate, Mexico. The deal expands Quasar's global CDMO capabilities, adds nearly 200 employees, and provides FDA-registered, ISO 13485-certified facilities to strengthen design, prototyping and high-volume manufacturing for medical device OEMs.

PainTEQ, a Tampa-based developer of minimally invasive sacroiliac (SI) joint implants, completed a majority growth recapitalization co-led by Signet Healthcare Partners and Windham Capital Partners with a new equity investment from MVolution Partners. The capital will fund clinical studies, next-generation product development and expansion of PainTEQ's U.S. commercial presence; transaction terms were not disclosed.

Terumo Corporation has agreed to acquire Oxford-based medtech company OrganOx for approximately $1.5 billion, bringing OrganOx into Terumo as a standalone division to scale adoption of its metra liver perfusion platform. The exit delivers a significant return to growth investor BGF (its largest-ever), alongside other early and later-stage backers, and is intended to leverage Terumo’s global infrastructure to expand OrganOx’s reach in transplant markets.